BioCentury
ARTICLE | Company News

Aduro, U.S. Department of Defense cancer news

September 17, 2012 7:00 AM UTC

Aduro received an $867,846 grant from DoD's Congressionally Directed Medical Research Programs (CDMRP) for preclinical development of a prostate cancer vaccine. The funds will be used to engineer List...